Literature DB >> 21130144

Essential role of toll-like receptor 2 in morphine-induced microglia activation in mice.

Yi Zhang1, Hui Li, Yi Li, Xiuli Sun, Mengyang Zhu, Gregory Hanley, Gene Lesage, Deling Yin.   

Abstract

Opioids are powerful pain relievers, but also potent inducers of dependence and tolerance. Chronic morphine administration (via subcutaneous pellet) induces morphine dependence in the nucleus accumbens, an important dependence region in the brain, yet the cellular mechanisms are mostly unknown. Toll-like receptor 2 (TLR2) plays an essential function in controlling innate and inflammatory responses. Using a knockout mouse lacking TLR2, we assessed the contribution of TLR2 to microglia activation and development of morphine dependence. We report here that mice deficient in TLR2 inhibit morphine-induced the levels of microglia activation and proinflammatory cytokines. Moreover, in TLR2 knockout mice the main symptoms of morphine withdrawal were significantly attenuated. Our data reveal that TLR2 plays a critical role in morphine-induced microglia activation and dependence. Copyright Â
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21130144      PMCID: PMC3018547          DOI: 10.1016/j.neulet.2010.11.063

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  30 in total

Review 1.  Toll-like receptors in innate immunity.

Authors:  Kiyoshi Takeda; Shizuo Akira
Journal:  Int Immunol       Date:  2005-01       Impact factor: 4.823

2.  In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.

Authors:  Kirsten M Raehal; John J Lowery; Castigliano M Bhamidipati; Ryan M Paolino; Jennifer R Blair; Danxin Wang; Wolfgang Sadée; Edward J Bilsky
Journal:  J Pharmacol Exp Ther       Date:  2005-02-16       Impact factor: 4.030

3.  IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates.

Authors:  Scott J Russo; Carlos A Bolanos; David E Theobald; Nathan A DeCarolis; William Renthal; Arvind Kumar; Catharine A Winstanley; Nora E Renthal; Matthew D Wiley; David W Self; David S Russell; Rachael L Neve; Amelia J Eisch; Eric J Nestler
Journal:  Nat Neurosci       Date:  2006-12-03       Impact factor: 24.884

4.  A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia.

Authors:  Seija Lehnardt; Philipp Henneke; Egil Lien; Dennis L Kasper; Joseph J Volpe; Ingo Bechmann; Robert Nitsch; Joerg R Weber; Douglas T Golenbock; Timothy Vartanian
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

5.  A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity.

Authors:  Donghoon Kim; Myung Ah Kim; Ik-Hyun Cho; Mi Sun Kim; Soojin Lee; Eun-Kyeong Jo; Se-Young Choi; Kyungpyo Park; Joong Soo Kim; Shizuo Akira; Heung Sik Na; Seog Bae Oh; Sung Joong Lee
Journal:  J Biol Chem       Date:  2007-03-13       Impact factor: 5.157

Review 6.  Cytokine and chemokine inter-regulation in the inflamed or injured CNS.

Authors:  Trevor Owens; Alicia A Babcock; Jason M Millward; Henrik Toft-Hansen
Journal:  Brain Res Brain Res Rev       Date:  2005-01-12

Review 7.  Emerging roles of caspase-3 in apoptosis.

Authors:  A G Porter; R U Jänicke
Journal:  Cell Death Differ       Date:  1999-02       Impact factor: 15.828

Review 8.  Toll-like receptors in central nervous system glial inflammation and homeostasis.

Authors:  Tammy Kielian
Journal:  J Neurosci Res       Date:  2006-04       Impact factor: 4.164

9.  Morphine promotes Jurkat cell apoptosis through pro-apoptotic FADD/P53 and anti-apoptotic PI3K/Akt/NF-kappaB pathways.

Authors:  Deling Yin; Michael Woodruff; Ying Zhang; Sarah Whaley; Junying Miao; Kenneth Ferslew; Jing Zhao; Charles Stuart
Journal:  J Neuroimmunol       Date:  2006-03-09       Impact factor: 3.478

10.  Toll-like receptor 2 signaling is a mediator of apoptosis in herpes simplex virus-infected microglia.

Authors:  Rajagopal N Aravalli; Shuxian Hu; James R Lokensgard
Journal:  J Neuroinflammation       Date:  2007-04-30       Impact factor: 8.322

View more
  34 in total

Review 1.  Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?

Authors:  Mark J Niciu; Ioline D Henter; Gerard Sanacora; Carlos A Zarate
Journal:  World J Biol Psychiatry       Date:  2013-09-12       Impact factor: 4.132

Review 2.  Opioid-induced central immune signaling: implications for opioid analgesia.

Authors:  Peter M Grace; Steven F Maier; Linda R Watkins
Journal:  Headache       Date:  2015-03-31       Impact factor: 5.887

Review 3.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

4.  Toll-like receptor 2 ligand pretreatment attenuates retinal microglial inflammatory response but enhances phagocytic activity toward Staphylococcus aureus.

Authors:  Travis Kochan; Anuj Singla; Joaquin Tosi; Ashok Kumar
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

Review 5.  Interictal pain in primary headache syndromes.

Authors:  Michael J Marmura; William B Young
Journal:  Curr Pain Headache Rep       Date:  2012-04

Review 6.  Commonalities and Distinctions Among Mechanisms of Addiction to Alcohol and Other Drugs.

Authors:  Angela R Ozburn; Aaron J Janowsky; John C Crabbe
Journal:  Alcohol Clin Exp Res       Date:  2015-10       Impact factor: 3.455

7.  Opioid activation of toll-like receptor 4 contributes to drug reinforcement.

Authors:  M R Hutchinson; A L Northcutt; T Hiranita; X Wang; S S Lewis; J Thomas; K van Steeg; T A Kopajtic; L C Loram; C Sfregola; E Galer; N E Miles; S T Bland; J Amat; R R Rozeske; T Maslanik; T R Chapman; K A Strand; M Fleshner; R K Bachtell; A A Somogyi; H Yin; J L Katz; K C Rice; S F Maier; L R Watkins
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

8.  Chronic morphine-induced microRNA-124 promotes microglial immunosuppression by modulating P65 and TRAF6.

Authors:  Shuwei Qiu; Yimin Feng; Gene LeSage; Ying Zhang; Charles Stuart; Lei He; Yi Li; Yi Caudle; Ying Peng; Deling Yin
Journal:  J Immunol       Date:  2014-12-24       Impact factor: 5.422

Review 9.  Neuroimmune mechanisms of psychostimulant and opioid use disorders.

Authors:  Rebecca S Hofford; Scott J Russo; Drew D Kiraly
Journal:  Eur J Neurosci       Date:  2018-09-26       Impact factor: 3.386

10.  Microglial activation involved in morphine tolerance is not mediated by toll-like receptor 4.

Authors:  Hiroshi Fukagawa; Tomohiro Koyama; Masahiro Kakuyama; Kazuhiko Fukuda
Journal:  J Anesth       Date:  2012-08-25       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.